David Egner Email & Phone Number

Dallas, Tx, Us

I lead practice acquisition, partnering, and other business development endeavors for this multi-hospital pediatric care system.

Dallas, Tx, Us

Dallas, Tx, Us

As an independent contractor, I provided market insights, strategic direction, and valuation and partnering expertise for biotech clients seeking specific funding or transaction goals.

Durham, Nc, Us

Bioventus started as a joint venture between Smith & Nephew and private equity investors led by Essex Woodlands. (Bioventus went public in February 2021.) I sourced opportunities and led cross-functional projects to in-license or acquire orthobiologic therapeutics for a 220-rep US direct sales force calling on orthopedic clinics and a nationwide surgical distributor-based business in surgical spine. I was responsible for projects soup to nuts: relationship management, technical and commercial assessment, terms negotiation, due diligence, management and board approvals, etc. My particular focus was on next-generation OA therapies, devices, biologics, and pharmaceuticals. Led the evaluation of more than 20 next-generation injectable osteoarthritis therapies, primarily pre-commercial investments with options; drove technical and commercial evaluation of injectable amniotic tissue therapies, negotiated term sheet with preferred partner for co-development and distribution, organized and led due diligence, oversaw market research projects Provided financial and strategic analysis to license and supply deal for hyaluronic acid therapy from IBSA and surgical spine biologics acquisitions (Advanced Biologics and BioStructures) Sourced tissue-bank partners for distribution of DBM and allograft chips to fill out spine portfolioNegotiated license for bone marrow aspirate needle to add unique cell offering to spine portfolio Sourced, negotiated and closed licensing deal for imaging equipment with diagnostic ultrasound manufacturer to add revenue to clinic portfolio Led strategic exploration of clinic-based solutions for tendinopathy and post-operative pain management to expand revenue opportunities Led special projects focused on strategic definition, revenue recovery, and a deal termination

Watford, Hertfordshire, Gb

Smith & Nephew is a leading medical technology business with global revenue of more than $4.6B in 100+ countries. Director, Business Development, Biologics Division, 2009-2012 (Durham, NC)Senior Business Development Manager, Orthopedic Trauma Division, 2004-2009 (Memphis, TN)Responsibility evolved from conducting competitive intelligence and market models to sourcing acquisitions and in-license ideas based on evolving market trends (e.g., extremities, biologics) and leading all aspects of deal projects Sourced and led evaluations of new clinic-based product opportunities, including diagnostics, injectables, topical pain treatments, and co-promoted pharmaceuticals. Negotiated licensing deals, distribution partnerships and investments for medical devices (Twin Star), surgical software (Orthocrat, University of Bristol), and development collaborations (Orthogon, University College London). Provided financial analysis to support VP-led deals (Q-Med)Provided financial analysis (and presented analysis to S&N Corporate) in support of two >$200M bids on spine companies, following three-month corporate investigation into spine opportunities, and negotiated the distribution of spine products in Germany Planned and led three-month integration of $20M product transfer between business unitsLed generation of competitive intelligence and market modeling for physician-administered osteoarthritis therapies and long-bone fracture repair

Nashville, Tennessee, Us

Nashville, Tn, Us

New York, New York, Us

Bachelor'S Degree, English, Economics

Mba, Finance